JP2025514489A5 - - Google Patents
Info
- Publication number
- JP2025514489A5 JP2025514489A5 JP2024564848A JP2024564848A JP2025514489A5 JP 2025514489 A5 JP2025514489 A5 JP 2025514489A5 JP 2024564848 A JP2024564848 A JP 2024564848A JP 2024564848 A JP2024564848 A JP 2024564848A JP 2025514489 A5 JP2025514489 A5 JP 2025514489A5
- Authority
- JP
- Japan
- Prior art keywords
- bag3
- vector
- polynucleotide
- expression
- brain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263337914P | 2022-05-03 | 2022-05-03 | |
| US63/337,914 | 2022-05-03 | ||
| PCT/US2023/020659 WO2023215266A1 (en) | 2022-05-03 | 2023-05-02 | Bag3 and protein quality control in the brain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025514489A JP2025514489A (ja) | 2025-05-02 |
| JP2025514489A5 true JP2025514489A5 (OSRAM) | 2026-05-14 |
Family
ID=88646932
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564848A Pending JP2025514489A (ja) | 2022-05-03 | 2023-05-02 | 脳におけるｂａｇ３およびタンパク質品質管理 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250289858A1 (OSRAM) |
| EP (1) | EP4518882A4 (OSRAM) |
| JP (1) | JP2025514489A (OSRAM) |
| KR (1) | KR20250010008A (OSRAM) |
| CN (1) | CN119255814A (OSRAM) |
| AU (1) | AU2023265031A1 (OSRAM) |
| CA (1) | CA3250880A1 (OSRAM) |
| CL (1) | CL2024003318A1 (OSRAM) |
| IL (1) | IL316559A (OSRAM) |
| MX (1) | MX2024013495A (OSRAM) |
| WO (1) | WO2023215266A1 (OSRAM) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4705326A1 (en) * | 2023-05-02 | 2026-03-11 | Research Institute at Nationwide Children's Hospital | Gene therapy for treatment of protein misfolding diseases |
| CN120478386B (zh) * | 2025-07-18 | 2025-10-17 | 南京大学 | 一种用于预防、改善和/或治疗阿尔茨海默症的siRNA及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1323733A1 (en) * | 2001-12-28 | 2003-07-02 | Arturo Leone | BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases |
| CA3228845A1 (en) * | 2014-01-31 | 2015-08-06 | Temple University Of The Commonwealth System Of Higher Education | Bag3 and uses thereof in the treatment of heart failure with reduced ejection fraction |
| CN109937045A (zh) * | 2016-08-11 | 2019-06-25 | 天普大学-联邦高等教育系统 | 局部缺血/再灌注损伤 |
| CN113286588A (zh) * | 2018-10-19 | 2021-08-20 | 阿克里普斯一有限公司 | 神经性疾病的治疗 |
| US20220023350A1 (en) * | 2018-11-04 | 2022-01-27 | Figene, Llc | Treatment of cerebral hypoxia including stroke, chronic traumatic encephalopathy, and traumatic brain injury |
| WO2020150377A1 (en) * | 2019-01-15 | 2020-07-23 | Temple University - Of The Commonwealth System Of Higher Education | Targeting the bag family for the treatment of neurodegenerative disease |
| WO2023069744A1 (en) * | 2021-10-22 | 2023-04-27 | Temple University Of The Commonwealth System Of Higher Education | Bag3 methods and uses for treatment of inflammation |
-
2023
- 2023-05-02 JP JP2024564848A patent/JP2025514489A/ja active Pending
- 2023-05-02 EP EP23799909.9A patent/EP4518882A4/en active Pending
- 2023-05-02 CA CA3250880A patent/CA3250880A1/en active Pending
- 2023-05-02 US US18/861,495 patent/US20250289858A1/en active Pending
- 2023-05-02 KR KR1020247039888A patent/KR20250010008A/ko active Pending
- 2023-05-02 AU AU2023265031A patent/AU2023265031A1/en active Pending
- 2023-05-02 WO PCT/US2023/020659 patent/WO2023215266A1/en not_active Ceased
- 2023-05-02 CN CN202380037961.7A patent/CN119255814A/zh active Pending
- 2023-05-02 IL IL316559A patent/IL316559A/en unknown
-
2024
- 2024-10-29 CL CL2024003318A patent/CL2024003318A1/es unknown
- 2024-10-31 MX MX2024013495A patent/MX2024013495A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022508182A5 (OSRAM) | ||
| JP2021106619A5 (OSRAM) | ||
| IL299325B2 (en) | Acid-alpha glucosidase variants and uses thereof | |
| JP2021003120A5 (OSRAM) | ||
| JP2022549380A5 (OSRAM) | ||
| CA3112883A1 (en) | Aav triple-plasmid system | |
| JP2022541070A5 (OSRAM) | ||
| KR20190032375A (ko) | 신규 아데노-관련 바이러스 캡시드 단백질 | |
| JP2022535749A5 (OSRAM) | ||
| JP2020520643A5 (OSRAM) | ||
| RU2018116076A (ru) | Модифицированные гены атаксии фридрейха и векторы для генной терапии | |
| JP2021512649A5 (OSRAM) | ||
| US20040087028A1 (en) | Ecdysone-inducible adeno-associated virus expression vectors | |
| EP2933335A1 (en) | A method of treating peripheral neuropathies and motor neuron diseases | |
| JP2022531809A5 (OSRAM) | ||
| JP2022524434A5 (OSRAM) | ||
| US20230049066A1 (en) | Novel aav3b variants that target human hepatocytes in the liver of humanized mice | |
| JP2023542614A5 (OSRAM) | ||
| JP2022551744A5 (OSRAM) | ||
| JP2023535620A5 (OSRAM) | ||
| JP2023537358A5 (OSRAM) | ||
| JP2023524024A5 (OSRAM) | ||
| JP2023509443A5 (OSRAM) | ||
| JP2023520763A5 (OSRAM) | ||
| JP2021534766A5 (OSRAM) |